Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising outcomes. However, the cost of this innovative drug and its availability have become key topics for patients and healthcare professionals. While tirzepatide has been approved by regulatory agencies, its high-priced nature presents a significant challenge to